These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 25856447)
1. Stroke prevention in nonvalvular atrial fibrillation: update on target-specific oral anticoagulants. Patrick C; Clarke R J Contin Educ Nurs; 2015 Apr; 46(4):152-4. PubMed ID: 25856447 [TBL] [Abstract][Full Text] [Related]
2. Benefits and risks of oral anticoagulation for stroke prevention in nonvalvular atrial fibrillation. Garcia DA Thromb Res; 2012 Jan; 129(1):9-16. PubMed ID: 22018997 [TBL] [Abstract][Full Text] [Related]
3. [Antithrombotic therapy in patients with first-ever stroke and known non-rheumatic atrial fibrillation]. Gandjour J; Zeindler J; Georgiadis D; Baumgartner RW Praxis (Bern 1994); 2005 Jan; 94(4):97-104. PubMed ID: 15732803 [TBL] [Abstract][Full Text] [Related]
4. Warfarin for stroke prevention in hemodialysis patients with non-valvular atrial fibrillation. Badr S; Cameron K; Battistella M CANNT J; 2015; 25(3):22-5; quiz 26-7. PubMed ID: 26882633 [No Abstract] [Full Text] [Related]
5. Oral Anticoagulants and Atrial Fibrillation: An Update for the Clinical Nurse. Spivak IE Medsurg Nurs; 2015; 24(2):95-100. PubMed ID: 26306367 [TBL] [Abstract][Full Text] [Related]
6. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?]. Selçuk H; Selçuk MT; Maden O Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079 [TBL] [Abstract][Full Text] [Related]
7. Do the current atrial fibrillation guidelines for stroke prevention need to be changed with the availability of new data on the new oral anticoagulants? Foley J; Lip GY Int J Clin Pract; 2012 May; 66(5):422-4. PubMed ID: 22512602 [No Abstract] [Full Text] [Related]
8. Comparative efficacy and safety of the non-vitamin K antagonist oral anticoagulants for patients with nonvalvular atrial fibrillation. Senoo K; Lip GY Semin Thromb Hemost; 2015 Mar; 41(2):146-53. PubMed ID: 25682085 [TBL] [Abstract][Full Text] [Related]
9. A new era of oral anticoagulation in atrial fibrillation: implications in clinical practice. Kasmeridis C; Lip GY; Apostolakis S Hosp Pract (1995); 2013 Feb; 41(1):61-70. PubMed ID: 23466968 [TBL] [Abstract][Full Text] [Related]
10. New anticoagulants (dabigatran, apixaban, rivaroxaban) for stroke prevention in atrial fibrillation. Aguilar MI; Kuo RS; Freeman WD Neurol Clin; 2013 Aug; 31(3):659-75. PubMed ID: 23896498 [TBL] [Abstract][Full Text] [Related]
11. Anticoagulation: stroke prevention in patients with atrial fibrillation. Waldo AL Cardiol Clin; 2009 Feb; 27(1):125-35, ix. PubMed ID: 19111769 [TBL] [Abstract][Full Text] [Related]
12. Review of challenges in optimizing oral anticoagulation therapy for stroke prevention in atrial fibrillation. Fernandez MM; von Schéele B; Hogue S; Kwong WJ Am J Cardiovasc Drugs; 2013 Apr; 13(2):87-102. PubMed ID: 23572283 [TBL] [Abstract][Full Text] [Related]
14. [Atrial fibrillation and stroke]. Aamodt AH; Sandset PM; Atar D; Tveit A; Russell D Tidsskr Nor Laegeforen; 2013 Aug; 133(14):1453-7. PubMed ID: 23929293 [TBL] [Abstract][Full Text] [Related]
15. Use of Warfarin at Discharge Among Acute Ischemic Stroke Patients With Nonvalvular Atrial Fibrillation in China. Yang X; Li Z; Zhao X; Wang C; Liu L; Wang C; Pan Y; Li H; Wang D; Hart RG; Wang Y; Wang Y; Stroke; 2016 Feb; 47(2):464-70. PubMed ID: 26696643 [TBL] [Abstract][Full Text] [Related]
16. [Stroke risk stratification in atrial fibrillation: oral anticoagulant therapy and bleeding risk in the elderly]. Poli D; Grifoni E Recenti Prog Med; 2011 Jan; 102(1):23-7. PubMed ID: 21516668 [TBL] [Abstract][Full Text] [Related]
17. Can patients at elevated risk of stroke treated with anticoagulants be further risk stratified? Baruch L; Gage BF; Horrow J; Juul-Möller S; Labovitz A; Persson M; Zabalgoitia M Stroke; 2007 Sep; 38(9):2459-63. PubMed ID: 17673721 [TBL] [Abstract][Full Text] [Related]
18. Misconceptions and Facts About Atrial Fibrillation. Argulian E; Conen D; Messerli FH Am J Med; 2015 Sep; 128(9):938-42. PubMed ID: 25827359 [TBL] [Abstract][Full Text] [Related]
19. Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation. Lip GY; Rushton-Smith SK; Goldhaber SZ; Fitzmaurice DA; Mantovani LG; Goto S; Haas S; Bassand JP; Camm AJ; Ambrosio G; Janský P; Al Mahmeed W; Oh S; van Eickels M; Raatikainen P; Steffel J; Oto A; Kayani G; Accetta G; Kakkar AK; Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2 Suppl 1):S12-20. PubMed ID: 25714828 [TBL] [Abstract][Full Text] [Related]
20. Practical considerations in the use of novel oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation. Deitelzweig S Cardiovasc Ther; 2014 Apr; 32(2):74-81. PubMed ID: 24119252 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]